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ments   represent an exemplary in developing herbal medications. 
Inspired by the results from the study of lingzhi, Professor Lin 
extended his research into many other medicinal herbs, including 
Tremella fuciformis, Wolfiporia extensa, and Lentinula edodes, and 
made many discoveries (Lin, 2011).
Professor Lin was a visiting scholar at University of Illinois at 
Chicago, USA, Honorary Professor at the Perm Pharmaceutical 
Research Institute, Russia, Adjunct Professor at more than 10 
Chinese University including Nankai University and Hongkong 
University. He was a member of the Chinese Pharmacopeia 
Committee, the Executive Committee at the International Union 
of Basic and Clinical Pharmacology (IUPHAR) and Southeast 
Asian Western Pacific Regional Federation of Pharmacologists 
(SEAWP-RFP), ex-President of the Chinese Pharmacological 
Society (CNPHARS), ex-President of the Standing Committee 
of Apitherapy at the International Federation of Beekeepers’ 
Associations (APIMONDIA).
During the past 10 years, Professor Lin has been focusing his 
efforts in modernizing the use of lingzhi. He set up a cultivation 
base, and standardized the pharmaceutical processes, including 
extraction and purification of the active components of lingzhi, 
and developed a set of criteria for quality control and assurance. 
Last but not least, Professor Lin is a great educator and a pioneer 
in disseminating scientific findings to the general public.
Ganoderma is a genus of polypore mushrooms and includes 
about 80 species. Ganoderma is characterized by basidiocarps 
that are large, perennial, woody brackets, also called “conks.” 
Ganoderma lucidum, also known as lingzhi, is the most com-
monly cultivated type of Ganoderma in China, and has been 
used for medical purposes for more than 2,000 years (Figure 1). 
Lingzhi is used in China for a great variety of purposes, including 
asthma, chronic obstructive pulmonary disease, sleep disorder, 
hepatitis, leucopenia, hypertension, hyperlipidemia, diabetes, 
and cancer. It is also widely used to promote health in those 
under a “sub-health” status (Lin, 2011).
Studies of lingzhi using modern technologies started in 1970s. 
Up to March 2012, 4,326 and 979 research papers have been depos-
ited into the Chinese CNKI and the Pubmed databases, using “ling-
zhi” and “Ganoderma” as search terms respectively.
Professor Zhi-Bin Lin is the leading pioneer in the research 
of lingzhi in the modern era (Figure 2). Interestingly, his name, 
in Chinese pronunciation, means as a soldier for lingzhi. Much 
of Professor Lin’s career was devoted to the research of lingzhi. 
He systematically studied the pharmacological actions of lingzhi, 
and identified a number of active ingredients responsible for the 
immune modulatory, anti-cancer, anti-diabetic, and anti-oxi-
dant properties of lingzhi. He and his colleagues also developed 
a series of pharmaceutical/nutraceutical products. His achieve-
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Figure 1 | Ganoderma lucidum (Leyss. ex Fr.) Karst. Figure 2 | Professor Zhi-Bin Lin.
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